Skip to main content
Premium Trial:

Request an Annual Quote

It's the MacGyver Approach to Microfluidics

Here's a blog post from the Wired folks describing a new microfluidics technology that could potentially be used for low-cost diagnostics in the developing world. From George Whitesides' group at Harvard, the technology is based on using a paper substrate with double-sided tape to keep costs down. "With a bit more work, the Harvard University chemists who devised the paper test could build a user-friendly, multi-layered microfluidics device with raw materials that cost roughly three cents," the story says.


The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.